PO4-3: Serum levels of insulin-like growth factor I (IGF-I) and insulin-like growth factor binding protein 3 (IGFBP-3) in women with cervical cancer

Abstract

analysis with height increment (cm/month) at 0 .4-1 .5 years as dependent variable, the addition of IGF-I at 0 .7 years (s=0 .36, P < 0 .05) to target height SDS (s=0 .50, P<0 .01), birth weight SDS and gestational age, increased the R2 from 22% to 33% (P < 0 .002) . Conclusion: Higher IGF-I and lower IGBP-1 at PMA 30-37 weeks reflect increased growth increment during this period . Height increment at 0 .4-1 .5 years correlated independently with both target height SDS and IGF-I levels during this period suggesting receptor/postreceptor differences in preterms with different target height SDS .